30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)
Clinical trial NCT01028391 · COMPLETED
Trial details
- NCT number
- NCT01028391
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-01-01
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.